About Us
about company
Who We Are
Wilmar International Limited, founded in 1991 and headquartered in Singapore, is today Asia’s leading agribusiness group. Wilmar is ranked amongst the largest listed companies by market capitalisation on the Singapore Exchange.
Wilmar’s business activities include oil palm cultivation, oilseed crushing, edible oils refining, flour and rice milling, sugar milling and refining, manufacturing of consumer products, ready-to-eat meals, central kitchen products, specialty fats, oleochemicals, biodiesel and fertilisers as well as food park operations.
Trusted
Clients
Finished
Projects
Years of
Experience
manufacturing
plants
what we do
Global Presence
Over 500 manufacturing plants and an extensive distribution network worldwide
Our History
Significant milestones in Wilmar’s growth journey.
Integrated Business
We are at every step of the entire value chain of the agricultural commodity business.
Leadership
Experienced and highly stable management with proven track record.
reliable & safe
Our Strategy Development
- Research
- aproach
- result
Wilmar’s research and development (R&D) activities support our business operations by improving manufacturing processes, ensuring the consistency and enhancing the quality of existing products as well as developing new innovative products.
Our R&D work is carried out by around 500 scientists and researchers, of which 80 hold doctorate qualifications. The R&D teams are based in various locations worldwide, including Singapore, China, Indonesia, India, Malaysia, Australia and New Zealand.
In line with the Group’s integrated and sustainable growth plan, our R&D teams engage in cross-border collaborations as well as with external organisations to share knowledge and resources to enhance our collective R&D effort. We were granted 79 patents in 2022 and a total of 371 patents to date.
Wilmar and the National University of Singapore (NUS) have established a new joint research laboratory to conduct cutting-edge clinical nutrition and synthetic biology research to create healthier food products as well as to devise green production technologies for industrial enzymes and biochemicals.
Officially launched in June 2018, the WIL@NUS Corporate Laboratory will leverage the capabilities of Wilmar and NUS to:
understand the impact of different food ingredients and foods on human health with focus on pregnant mothers, infants and the elderly;
address major public health issues through identifying food ingredients and food components capable of modulating glycemic index, lowering triglycerides and cholesterol.
Develop cost-effective and sustainable bio-based methods to produce industrial enzymes and biochemicals; and
integrate Photonics and Artificial Intelligence (AI) to develop fast methods for detection of food toxins, improving quality control and ensuring food safety.
For food R&D, Wilmar is collaborating with world-class clinical research facilities and medical experts at the NUS Medical School who are advancing our understanding of the role of food in the prevention of metabolic disorders such as Type II diabetes, obesity and cardiovascular conditions.
